{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:32:34Z","timestamp":1775151154969,"version":"3.50.1"},"reference-count":77,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,9,2]]},"DOI":"10.1080\/14656566.2022.2113384","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T02:34:34Z","timestamp":1660703674000},"page":"1545-1557","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Approved and emerging Bruton\u2019s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia"],"prefix":"10.1080","volume":"23","author":[{"given":"Alycia","family":"Hatashima","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Karami","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazyar","family":"Shadman","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA"},{"name":"Department of Medicine, Medical Oncology Division, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1908213"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-021-00973-6"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26367"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29566"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2005943"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.259432"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2349"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.2282"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30029-8"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00979"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-0715-5"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0602-x"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25638"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812836"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153146"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817073"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30788-5"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01485-x"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03355"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146570"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148457"},{"key":"cit0027","unstructured":"Hillmen P, Eichhorst B, Brown JR, et al. First interim analysis of ALPINE study: results of a phase III randomized study of zanubrutinib vs ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma. European Hematology Association (EHA); 2021 June. Virtual Congress."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147599"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148672"},{"issue":"4","key":"cit0031","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2021.280061","volume":"107","author":"Allan JN","year":"2021","journal-title":"Haematologica"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.87"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30443-5"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01580"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-785998"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2021.03.011"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000412"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01594"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511527"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030771"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687458"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146610"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116739"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2016.07.005"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006434"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012315"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651125"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2856"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"cit0050","unstructured":"Nct. A study of pirtobrutinib (LOXO-305) versus bendamustine plus rituximab (BR) in untreated patients with chronic lymphocytic leukemia (CLL)\/small lymphocytic lymphoma (SLL). 2021. Available from: https:\/\/clinicaltrialsgov\/show\/NCT05023980"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-846808"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000118"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.06.016"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13020"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.182907"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01252-y"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018884940"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005621"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2014.218"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1948"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.233.233"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-870238"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030007"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.272500"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148544"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900574"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-131732"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148666"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00807"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00491"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2809"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01241-1"},{"key":"cit0073","unstructured":"Nct. Ibrutinib and obinutuzumab with or without venetoclax in treating older patients with untreated chronic lymphocytic leukemia. 2018. Available from: https:\/\/clinicaltrialsgov\/show\/NCT03737981"},{"key":"cit0074","unstructured":"Nct. Ibrutinib and obinutuzumab with or without venetoclax in treating patients with chronic lymphocytic leukemia. 2018. Available from: https:\/\/clinicaltrialsgov\/show\/NCT03701282"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00455-1"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00307-0"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114110"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2113384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T05:56:43Z","timestamp":1672034203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2113384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":77,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,9,2]]}},"alternative-id":["10.1080\/14656566.2022.2113384"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2113384","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}